181 related articles for article (PubMed ID: 15645682)
1. PDA Virus Filter Task Force update.
Sofer G
Dev Biol (Basel); 2004; 118():129-31. PubMed ID: 15645682
[TBL] [Abstract][Full Text] [Related]
2. Use of bacteriophages as surrogates for mammalian viruses.
McAlister M; Aranha H; Larson R
Dev Biol (Basel); 2004; 118():89-98. PubMed ID: 15645677
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
Furuya K; Murai K; Yokoyama T; Maeno H; Takeda Y; Murozuka T; Wakisaka A; Tanifuji M; Tomono T
Vox Sang; 2006 Aug; 91(2):119-25. PubMed ID: 16907872
[TBL] [Abstract][Full Text] [Related]
4. Virus removal by filtration.
Graf EG; Jander E; West A; Pora H; Aranha-Creado H
Dev Biol Stand; 1999; 99():89-94. PubMed ID: 10404880
[TBL] [Abstract][Full Text] [Related]
5. A consensus rating method for small virus-retentive filters. I. Method development.
Lute S; Riordan W; Pease LF; Tsai DH; Levy R; Haque M; Martin J; Moroe I; Sato T; Morgan M; Krishnan M; Campbell J; Genest P; Dolan S; Tarrach K; Meyer A; ; Zachariah MR; Tarlov MJ; EtzeL M; Brorson K; Aranha H; Bailey M; Bender J; Carter J; Chen Q; Dowd C; Jani R; Jen D; Kidd S; Meltzer T; Remington K; Rice I; Romero C; Sato T; Jornitz M; Sekura CM; Sofer G; Specht R; Wojciechowski P;
PDA J Pharm Sci Technol; 2008; 62(5):318-33. PubMed ID: 19055228
[TBL] [Abstract][Full Text] [Related]
6. European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products.
Celis P; Silvester G
Dev Biol (Basel); 2004; 118():3-10. PubMed ID: 15645667
[TBL] [Abstract][Full Text] [Related]
7. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
[TBL] [Abstract][Full Text] [Related]
8. Multi-round virus filter integrity test sensitivity.
Dowd CJ
Biotechnol Bioeng; 2009 Jun; 103(3):574-81. PubMed ID: 19253932
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anti-viral filters.
Hughes B; Bradburne A; Sheppard A; Young D
Dev Biol Stand; 1996; 88():91-8. PubMed ID: 9119168
[TBL] [Abstract][Full Text] [Related]
10. Removal of virus through novel membrane filtration method.
Manabe S
Dev Biol Stand; 1996; 88():81-90. PubMed ID: 9119166
[TBL] [Abstract][Full Text] [Related]
11. Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions.
Roberts PL; Feldman P; Crombie D; Walker C; Lowery K
Biologicals; 2010 Mar; 38(2):303-10. PubMed ID: 20089418
[TBL] [Abstract][Full Text] [Related]
12. PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document--A Progress Report.
King K; Wiebe M
PDA J Pharm Sci Technol; 2011; 65(6):693. PubMed ID: 22294602
[TBL] [Abstract][Full Text] [Related]
13. Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives.
Kreil TR; Wieser A; Berting A; Spruth M; Medek C; Pölsler G; Gaida T; Hämmerle T; Teschner W; Schwarz HP; Barrett PN
Transfusion; 2006 Jul; 46(7):1143-51. PubMed ID: 16836561
[TBL] [Abstract][Full Text] [Related]
14. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
Farshid M; Taffs RE; Scott D; Asher DM; Brorson K
Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
[TBL] [Abstract][Full Text] [Related]
15. EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
Biologicals; 1991 Jul; 19(3):247-51. PubMed ID: 1954007
[No Abstract] [Full Text] [Related]
16. Membrane filtration for virus removal.
Brandwein H; Aranha-Creado H
Dev Biol (Basel); 2000; 102():157-63. PubMed ID: 10794103
[TBL] [Abstract][Full Text] [Related]
17. SWNT-MWNT hybrid filter attains high viral removal and bacterial inactivation.
Brady-Estévez AS; Schnoor MH; Kang S; Elimelech M
Langmuir; 2010 Dec; 26(24):19153-8. PubMed ID: 21090770
[TBL] [Abstract][Full Text] [Related]
18. Viral safety of C1-inhibitor NF.
Terpstra FG; Kleijn M; Koenderman AH; Over J; van Engelenburg FA; Schuitemaker H; van 't Wout AB
Biologicals; 2007 Jun; 35(3):173-81. PubMed ID: 17071103
[TBL] [Abstract][Full Text] [Related]
19. "Large pore size" virus filter test method recommended by the PDA Virus Filter Task Force.
Brorson K; Sofer G; Robertson G; Lute S; Martin J; Aranha H; Haque M; Satoh S; Yoshinari K; Moroe I; Morgan M; Yamaguchi F; Carter J; Krishnan M; Stefanyk J; Etzel M; Riorden W; Korneyeva M; Sundaram S; Wilkommen H; Wojciechowski P
PDA J Pharm Sci Technol; 2005; 59(3):177-86. PubMed ID: 16048117
[No Abstract] [Full Text] [Related]
20. A consensus rating method for small virus-retentive filters. II. Method evaluation.
Brorson K; Lute S; Haque M; Martin J; Sato T; Moroe I; Morgan M; Krishnan M; Campbell J; Genest P; Parrella J; Dolan S; Martin S; Tarrach K; Levy R; ; Aranha H; Bailey M; Bender J; Carter J; Chen Q; Dowd C; Jani R; Jen D; Kidd S; Meltzer T; Remington K; Rice I; Romero C; Sato T; Jornitz M; Sekura CM; Sofer G; Specht R; Wojciechowski P
PDA J Pharm Sci Technol; 2008; 62(5):334-43. PubMed ID: 19055229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
